在线血液过是传统血液透析的经济有效替代方案吗?
Kevin F Erickson1, James Fotheringham2
1Section of Nephrology, Baylor College of Medicine, Houston, Texas, USA; Baker Institute for Public Policy, Rice University, Houston, Texas, USA.
Kidney international
|March 21, 2025
概括
血液过在一些国家显示成本效益在接受的门范围内,但并非所有国家. 决策者 决策者 决策者
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 卫生经济学 卫生经济学
背景情况:
- 血液透析是对末期病的常见治疗方法.
- 血液过是一种具有潜在益处的替代治疗方式.
研究的目的:
- 进行血液过与传统高流量血液透析的成本效益分析.
- 用CONVINCE试验数据评估血液过的经济可行性.
主要方法:
- 成本效益分析. 成本效益分析.
- 利用了高剂量血液过与高流量血液透析 (CONVINCE) 试验的数据.
主要成果:
- 血液过的成本效益在某些国家被接受的支付意愿门内.
- 它被发现接近,但在其他国家的下限值之外.
- 治疗成本的估值和国家特定的门对成本效益有重大影响.
结论:
- 血液过的成本效益是可变的,并且取决于国家经济因素.
- 关于采用血液过的决策需要考虑国家特定的支付意愿门.
更多相关视频
相关概念视频
Dialysis
244
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
244
Heart Failure Drugs: Diuretics
312
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
312
Renal Failure: Dose Adjustments
51
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
51


